Editas Medicine, Inc.·4

Feb 9, 5:24 PM ET

Cox Gerald Frank 4

4 · Editas Medicine, Inc. · Filed Feb 9, 2018

Insider Transaction Report

Form 4
Period: 2018-02-07
Cox Gerald Frank
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-02-07+60,00060,000 total
    Exercise: $36.67Exp: 2028-02-06Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]This option was granted on February 7, 2018 and is scheduled to vest over four years in equal monthly installments beginning on February 7, 2018 through February 7, 2022.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -